Small-cell lung cancer is when abnormal cells in your lung grow fast and uncontrollably. It’s an aggressive form of cancer that often starts in your airways and then spreads, or metastasizes, to ...

The big problem comes when lung cancer cells — which typically develop from AT2 cells — take on some “remembered” properties of the AT1 cells that AT2 cells differentiate into when they’re playing ...

In this retrospective cohort study, the presence of tumor-infiltrating clonal hematopoiesis (TI-CH) was associated with an ...

In the context of lung adenocarcinoma, which is a major form of cancer originating from AT2 cells, understanding how aging affects stem cell behavior is essential for advancing cancer prevention ...

New research highlights the promise of a novel stem cell treatment strategy for leptomeningeal brain metastasis (LBM), a severe form of metastatic brain cancer that spreads to membranes ...

Researchers in Japan have successfully generated lung cells similar to alveolar epithelial type 2 (AT2) cells from mouse ...

Non-small-cell lung cancer is the most common type, accounting for about 85% of cases. ... Or it might stem from a condition such as asthma or a chest infection.

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations.

Scientists create hydrogel that 'reprograms' cancer cells into stem cells in 24 hours. ... lung, uterine, colon, bladder, and sarcoma cancer cells. Cancer cell reprogramming.

Scripps’ lung medicine activates stem cells in the lower airways, known as type 2 alveolar epithelial (AEC2) cells, responsible for manufacturing crucial cells for exchanging stale oxygen for fresh.